Office for Human Research Protections

Office for Human Research Protections
Name	Office for Human Research Protections
Formed	2000
Preceding1	Office for Protection from Research Risks
Jurisdiction	United States Department of Health and Human Services
Headquarters	Rockville, Maryland
Parent agency	United States Department of Health and Human Services

Contents

Office for Human Research Protections

The Office for Human Research Protections is a federal office within the United States Department of Health and Human Services responsible for overseeing ethical standards and regulatory compliance for human subjects research in the United States. It evolved from earlier entities addressing research ethics and responds to developments in clinical trials, bioethics, and biomedical innovation involving institutions such as National Institutes of Health, Food and Drug Administration, Centers for Disease Control and Prevention, Veterans Health Administration, and National Cancer Institute. The office interfaces with international bodies including World Health Organization, Council of Europe, European Medicines Agency, and International Council for Harmonisation.

History

The office traces administrative roots to the aftermath of scandals like the Tuskegee syphilis experiment and policy reports such as the National Research Act and the Belmont Report, which prompted creation of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research and later institutional structures including the Office for Protection from Research Risks and successor entities within Public Health Service. Key moments in the office's history intersect with events and institutions like the Nuremberg Trials, the Declaration of Helsinki, the Reagan administration, the Clinton administration, the Bush administration, and the Obama administration as health policy and human subjects protections evolved alongside programs at the Centers for Medicare & Medicaid Services and partnerships with universities such as Harvard University, Johns Hopkins University, Stanford University, and Yale University. Its regulatory maturation paralleled jurisprudence in cases involving rights established in Roe v. Wade era debates, media coverage by outlets like The New York Times and The Washington Post, and academic scrutiny published in journals including The New England Journal of Medicine and The Lancet.

The office's mission aligns with principles articulated in the Belmont Report and informs operations at institutions such as Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, and networks like All of Us Research Program. Functions include assuring compliance with federal regulations affecting projects funded by agencies like National Science Foundation, Department of Defense, National Institute of Allergy and Infectious Diseases, and oversight coordination with ethics committees at University of California, San Francisco, Columbia University, Princeton University, and private sponsors including Pfizer, Moderna, Johnson & Johnson, and GlaxoSmithKline. The office engages with professional organizations such as the American Medical Association, Association of American Medical Colleges, American Psychological Association, Society for Clinical Trials, and collaborates on guidance used by institutional review boards at institutions like MIT, Duke University, University of Pennsylvania, and University of Michigan.

Regulatory authority derives from statutes and federal regulations including provisions in the Public Health Service Act, provisions affected by the Common Rule, and coordination with Food and Drug Administration oversight of investigational new drug applications and clinical investigations. Policy instruments reference documents such as the Belmont Report, guidance from the National Academies of Sciences, Engineering, and Medicine, and alignment with international frameworks like the Declaration of Helsinki and processes involving the International Council for Harmonisation. The office issues guidance used by awardees including Howard Hughes Medical Institute investigators, military research offices like United States Army Medical Research and Development Command, and philanthropic entities such as the Gates Foundation.

The office sits within the Office of the Assistant Secretary for Health alongside offices addressing policy areas tied to agencies such as Centers for Disease Control and Prevention and Substance Abuse and Mental Health Services Administration. Leadership roles coordinate with advisory bodies including the Secretary's Advisory Committee on Human Research Protections and interact with institutional review boards at universities like Cornell University, Brown University, Vanderbilt University, and Rice University. The office's staff includes policy analysts, compliance officers, and subject matter experts who liaise with federal partners such as Department of Veterans Affairs, Department of Energy, and international partners like European Commission representatives.

Major programs address implementation of the Common Rule revisions, training initiatives for human subjects protections used at institutions such as Georgetown University and Emory University, development of guidance on clinical trial registration with ClinicalTrials.gov stakeholders, data sharing policies intersecting with projects like the Human Genome Project and All of Us Research Program, and emergency-response research facilitation during outbreaks tracked by Centers for Disease Control and Prevention, World Health Organization, and Pan American Health Organization. Initiatives have engaged industry partners including AstraZeneca, Novartis, Roche, and academic consortia like CTSA Program.

The office has played oversight or consultative roles in high-profile investigations involving research at institutions such as Gupta scandal-type cases at leading universities, clinical trial irregularities involving sponsors like GlaxoSmithKline and Pfizer, and inquiries tied to research misconduct reviews by bodies like the Office of Research Integrity. Cases have intersected with legal processes in courts such as the United States District Court for the District of Columbia and have provoked Congressional attention from committees like the United States Senate Committee on Health, Education, Labor, and Pensions and the United States House Committee on Oversight and Reform.

Criticism has arisen from academic commentators in outlets like Science (journal), Nature (journal), and from advocacy organizations such as American Civil Liberties Union and National Association for the Advancement of Colored People regarding perceived gaps in protection for vulnerable populations highlighted by historical cases like the Tuskegee syphilis experiment and debates over consent standards influenced by reports from The Hastings Center and rulings from courts including Supreme Court of the United States precedents. Reforms have been proposed through rulemaking processes involving stakeholders such as Association of American Universities, Research!America, and legislative proposals debated in the United States Congress to adapt to challenges posed by big data projects at Google and Amazon affiliates, gene-editing research from laboratories linked to CRISPR-Cas9 developments, and international collaborative trials coordinated with entities like World Health Organization.